Venture Life Group plc

LSE VLG.L

Venture Life Group plc Price to Book Ratio (P/B) on January 14, 2025: 0.60

Venture Life Group plc Price to Book Ratio (P/B) is 0.60 on January 14, 2025, a -0.71% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • Venture Life Group plc 52-week high Price to Book Ratio (P/B) is 0.88 on September 30, 2024, which is 47.49% above the current Price to Book Ratio (P/B).
  • Venture Life Group plc 52-week low Price to Book Ratio (P/B) is 0.57 on January 31, 2024, which is -5.16% below the current Price to Book Ratio (P/B).
  • Venture Life Group plc average Price to Book Ratio (P/B) for the last 52 weeks is 0.70.
Key data
Date Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield Price to Earnings Ratio (P/E)
Market news
Loading...
LSE: VLG.L

Venture Life Group plc

CEO Mr. Jeremy Anthony Philip Randall ACA
IPO Date March 28, 2014
Location United Kingdom
Headquarters 12 The Courtyard
Employees 165
Sector Health Care
Industries
Description

Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. It operates through Venture Life Brands and Customer Brands segments. The company offers neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance alertness, cognitive function, and mental performance in healthy brain; and Original Bioscalin to treat and prevent hair loss, hair thinning, and baldness. It also provides Fungal Nail Solution, which helps to treat and prevent fungal infections; and Fungal Nail Cleanser for the hygiene of hands and feet prone to fungal nail infections under the Myco Clear brand name. In addition, the company offers UltraDEX product for bad breath; Dently Dual Action, a mouthwash, which lifts and removes plaque and bacteria from the teeth and gums; and Procto-eze plus for anal irritation, including haemorrhoids condition. Further, it provides women healthcare products comprising vonalei bacterial vaginosis, a refreshing gel; vonalei Vaginal Atrophy, a vaginal cream; vonalei candidiasis, a soothing cream-gel for thrush; and vonalei intimate cleansing foam. Additionally, it offers Cleansing Foam, Cleansing Cream, and Serum under the Rosa calma brand name; and skincare ranges to hydrate, nourish, and recondition the skin, as well as to prevent the lines and wrinkles under the Lubatti Classic and the Lubatti Anti-age brand names. The company sells its products through a network of international partners, retail pharmacies, as well as grocery multiple retailers. Venture Life Group plc was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.

Similar companies

KETL.L

Strix Group Plc

USD 0.58

0.19%

KMK.L

Kromek Group plc

USD 0.06

0.09%

SRC.L

SigmaRoc plc

USD 0.87

-0.89%

StockViz Staff

January 15, 2025

Any question? Send us an email